Immune reconstitution after highly active antiretroviral treatment of HIV infection
- 1 January 2001
- book chapter
- Published by Springer Nature
- Vol. 495, 205-212
- https://doi.org/10.1007/978-1-4615-0685-0_28
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Prolonged Suppression of Human Immunodeficiency Virus Type 1 (HIV?1) Viremia in Persons with Advanced Disease Results in Enhancement of CD4 T Cell Reactivity to Microbial Antigens but Not to HIV?1 AntigensThe Journal of Infectious Diseases, 1999
- Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humansNature Medicine, 1999
- Changes in thymic function with age and during the treatment of HIV infectionNature, 1998
- Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 diseaseThe Lancet, 1998
- In vivo analysis of Fas/FasL interactions in HIV-infected patients.Journal of Clinical Investigation, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Decline in deaths from AIDS due to new antiretroviralsThe Lancet, 1997
- The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and ZalcitabineNew England Journal of Medicine, 1996